hematopoietic system
[용어속성] Term
In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor
유인 수용체를 사용한 SARS-CoV2 감염에 대한 생체 내 조혈 줄기 세포 유전자 치료
Article
[키워드] abundance
Adenovirus
adjust
airway
Antiviral
antiviral efficacy
approach
approaches
Bone marrow
CD46
Cell
creating
cytokine
cytokine production
decoy
decoy receptor
diminishe
dose
effector proteins
elements
erythrocytes
erythroid cells
erythropoiesis
example
expressed
expression
Gene therapy
hematopoietic
Hematopoietic stem cell
hematopoietic system
in vivo
in vivo HSC gene therapy.
Infection
Intervention
Intravenous injection
less
lethal dose
Lung pathology
mice
neutralizing capacity
not affect
performed
Peripheral blood
pilot study
Prophylaxis
reached
receptor
receptor protein
reduced
Regulatory
resulting
rhesus
rhesus macaque
sACE2
SARS-CoV2
SARS-CoV2 infection
SARS-CoV2 vaccine
SARS-CoV2 vaccines
secreted
shown
significantly
spleen
STEM
stem cell
survived
susceptible
Symptoms
therapy
transcriptional
transduced
Vaccine
variant
Viremia
while
β-globin
[DOI] 10.1089/hum.2021.295 PMC 바로가기 [Article Type] Article
[DOI] 10.1089/hum.2021.295 PMC 바로가기 [Article Type] Article
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial
중증 급성 호흡기 증후군이 있는 COVID-19 환자 관리에 대한 중국 전통 의학 Maxingshigan-Weijing의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
administration
Affiliated Hospital
age
allergic
allergies
anorexia
anti-bacterial
Anti-viral
anticipated
Anxiety
Arm
asked
Asymptomatic
automatically
aversion
blinded
Blinding
Blood tinged
blood tinged sputum
both groups
Care
carried
center
checklist
Chenpi
chest pain
chest X-ray
Chinese
Chinese Clinical Trial Registry
Chinese herbal medicines
clinical
clinical symptom
clinical trials
clinically
Cold
comparator Patients
composed
control group
Controlled trial
coronavirus
cough
COVID-19
COVID-19 patient
criteria
critical patient
critical patients
defined
diarrhea
disease
Diseases
dissemination
distension
Dizziness
dry mouth
dysphoria
effective
Efficacy
element
Eligible patients
ephedra
exclusion criteria
expectoration
female
Fever
Follow-up
four-point scale
Gypsum
H1N1
H1N1 influenza
headache
hematopoietic system
Herba Ephedra
herbal medicine
hospital
IBM
IBM Corp
IMPROVE
improvement
in both group
include
Inclusion
inclusion and exclusion criteria
inclusion criteria
individual
Influenza
Informed consent
Inpatient
Insomnia
Kaplan-Meier method
kidney
Kidney function
lactation
less
liver
log-rank test
malaise
male
management
Maxingshigan-weijing
mechanical ventilation
Medicine
Melon
Mild
mild clinical symptoms
multicenter
multiple organ failure
muscular
nasal
nasal obstruction
nausea
nausea and vomiting
negative test
nucleic acid
number
objective
open
Open-label
oral administration
outcome
participant
Patient
patients
Peach
pharyngalgia
Pneumonia
positive
Pregnancy
previous study
Primary outcome
Professor
proportion
protocol
Radix
random
random allocation
random number generator
randomisation
randomised
Randomized
Randomized controlled trial
randomly divided
receive
recruited
registry
reported
researcher
respiratory
Respiratory failure
respiratory symptom
Sample size
SARS-CoV-2
SARS-CoV-2 nucleic acid
Scoring
second
secondary
Secondary outcomes
Semen
sequence
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severity
Shock
Shortness of breath
statistical analysis
Statistical power
Statistics
status
Study protocol
suffering
supplementary material
supportive care
survival
survival time
sweating
Symptom
symptomatic
Symptoms
System
TCM
temperature
test results
the median
therapy
total score
Traditional
Traditional Chinese medicine
treated
Treatment
trial protocol
Trial registration
Trichosanthe
Trichosanthes Kirilowii
university
USA
Version
virus pneumonia
vomiting
website
wheezing
Winter
Withdrawal
[DOI] 10.1186/s13063-020-04970-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04970-3 PMC 바로가기 [Article Type] Letter
Identifying side effects of commonly used drugs in the treatment of Covid 19
Covid 19 치료에 일반적으로 사용되는 약물의 부작용 식별
Review
[키워드] addition
Adverse reaction
Adverse reactions
Atazanavir
cardiovascular system
caused
clinical study
COVID-19 treatment
drug
Drug safety
drug-drug interaction
Drug-drug interactions
drugs
drugs in combination
estimate
experimental results
experiments
facilitate
graph
hematopoietic system
heparin
identifying
information technology
Interaction
other organs
Patient
patients
produced
Side effect
Side effects
Treatment
[DOI] 10.1038/s41598-020-78697-1 PMC 바로가기 [Article Type] Review
[DOI] 10.1038/s41598-020-78697-1 PMC 바로가기 [Article Type] Review